Kevin Appareti – Senior Director, Global Medical Science Liaison
Kevin Appareti is Senior Director, Global Medical Science Liaison in the Chief Medical Office at Royal Philips. He leads the Key Thought Leadership Program and works across Philips’ businesses, markets, and research to build strong internal and external relationships with key thought leaders and influencers. Kevin partners with internal business, market, and research leaders to develop strategic Key Thought Leader (KTL) engagement programs to deliver strategic guidance, leverage clinical and scientific knowledge, foster peer-to-peer relationships, and support clinical and marketing evidence development in support of Philips meaningful innovations.
Prior to the 7 years he has been in the Chief Medical Office, he had 25 years of experience in the Ultrasound Business Unit where he held a variety of leadership positions. He was senior marketing manager of the global luminary program where he contributed to establishing a structured approach to thought leader management. He was also worldwide market development manager and director of product marketing for cardiovascular ultrasound where he brought to market many cardiovascular ultrasound products that set the standard in performance and reliability. He has held additional positions in marketing management for professional services, information technologies and clinical marketing.
He began his academic, research and clinical career as Program Director for Diagnostic Medical Ultrasound Education at the University of Colorado Health Sciences Center where he was involved in clinical research in fetal echocardiography, neonatal brain imaging, and ultrasound technology assessment. He has co-authored many scientific papers, book chapters and presented at numerous international scientific conferences.
He then moved to an industry with various clinical and management roles with Hewlett Packard, Agilent Technologies, and now Royal Philips. Kevin holds a bachelor’s degree in physical science from Colorado State University and an MBA from Boston University and has been an adjunct professor at the University of Massachusetts at Lowell, Manning School of Business.
Kevin is married and has 4 boys. He enjoys basketball, road cycling, tennis and he is an avid photographer.
Jacqueline S. Armani, O.D., F.A.A.O., graduated from the New England College of Optometry, externed at Bascom Palmer and practiced at the VA as a primary care and ocular disease resident optometrist. Jackie has extensive experience training and mentoring residents and students and is a Fellow of the American Academy of Optometry. She joined industry following years of clinical practice as Executive Clinical Outcomes Specialist at Bausch and Lomb. Jackie is now a Medical Science Liaison at Alcon Surgical where she supports over 20 products in 6 product categories. Jackie’s career has included her medical mission in Colombia with VOSH and South Africa with OneSight Global. She resides in New York, volunteers on her alumni board, and loves to travel and plan events.
Senior Director and Head, Global Medical Strategy and Training
Terry Babb – Senior Director and Head, Global Medical Strategy and Training
President- THE DOCTOR'S CHANNEL
Michael Banks – Managing Director
Executive Director, Compliance and Ethics
Tina Beamon – Executive Director, Compliance and Ethics
Tina Clark Beamon, Esq. is the Executive Director, Compliance and Ethics responsible globally for R&D and Manufacturing Operations. Tina joined Alexion in December of 2016.
Tina is an attorney with 21 years of experience in the healthcare industry. Tina spent 9 years at Boehringer Ingelheim Pharmaceuticals where she served as the lead attorney for the Oncology Division in the US as well as the Consumer Healthcare Division. She also provided legal support for the Sunshine Act Implementation Project. Additionally, Tina spent 5 years as Counsel and Secretary for the BICARES Foundation, a separate legal entity housing the company’s philanthropic interests. The BICARES Foundation operated the Patient Assistance Program for US patients and the Product Donation Program (donation of bulk product to third party NGOs managing donations ex-US and for disaster relief), evaluated requests for charitable contributions in line with areas of interest and coordinated company sanctioned volunteerism.
Tina started her career as a healthcare associate at Wiggin and Dana and Neubert Pepe and Monteith, PC. A native of the New Haven area, Tina has served on the Board of Directors and as a volunteer for many community based organizations within New Haven, including CT CASA and the Lawyer’s Collaborative for Diversity.
Executive Medical Director
Colville Brown, M.D., is presently the Medical Director at Egalet U.S. Inc. He received his medical degree with honors from Howard University and was trained in Internal Medicine at the Hospital of the University of Pennsylvania. After leaving residency he served as Assistant Director at a long-term care facility for the intellectually disabled. In 2010, he joined AlphaBioCom where he served in roles of increasing responsibility to become Director of Clinical and Medical Affairs. Dr. Brown joined Egalet in 2016 where he plays a key role in the development and implementation of Medical Affairs activities.
Director, U.S. Medical Affairs
Ryan Case – Director, U.S. Medical Affairs
Medical Director, Therapeutic Area Head
Joseph Chiao – Medical Director, Therapeutic Area Head
Martin Conner, Pharm.D., MBA
Field Director, Medical Science Liaisons - Women's Health
Stacy Conner – Field Director, Medical Science Liaisons - Women's Health
Dickerson, Ph.D., M.Sc., MBA
Regional Medical Director, Orphan and Rare Diseases
Duke Dickerson – Regional Medical Director, Orphan and Rare Diseases
Distinguished Visiting Practitioner and Adjunct Professor
SETON HALL UNIVERSITY SCHOOL OF LAW
Howard Dorfman – Distinguished Visiting Practitioner and Adjunct Professor
SETON HALL UNIVERSITY SCHOOL OF LAW
Howard L. Dorfman is Founder of H.L. Dorfman Pharmaceutical Consulting, LLC providing compliance, regulatory and risk management consulting services to pharmaceutical and biotech companies and law firms.
His areas of expertise include FDA regulatory law, fraud and abuse, health care compliance, risk management, corporate governance, and litigation.
Mr. Dorfman served as Vice President and General Counsel at Ferring Pharmaceuticals, Inc. in Parsippany, New Jersey where he was responsible for all legal matters relating to the U.S. affiliate of a Swiss-based global pharmaceutical and biotech company. Previously, he served as a Counsel in the Life Sciences group at Ropes & Gray LLP in New York where his practice focused on compliance and regulatory issues relating to the pharmaceutical, biotech, and medical device industries.
Prior to joining Ropes & Gray, Mr. Dorfman was the chief legal officer of the pharmaceutical division of Bayer Healthcare LLC. Before joining Bayer, he was a member of the Bristol-Myers Squibb legal department as Counsel in the Litigation group involved in defense of nationwide product liability litigation and later as Counsel to the US Medicines Group involved in regulatory, compliance and commercial work.
Mr. Dorfman is an adjunct professor at Seton Hall University School of Law and has lectured and published articles on a range of issues including compliance, regulatory and litigation. He is Editor and Contributing Author of the Practising Law Institute Pharmaceutical Compliance and Enforcement Answer Book, now in its fourth edition. He received his B.A. with honors from Yeshiva University and his J.D. degree from Brooklyn Law School.
M. Goodwin, Pharm.D., MBA
Director, Medical Affairs
Matthew Goodwin – Director, Medical Affairs
Hennessy, Ph.D., M.S., MBA
Vice President, Field Medical Affairs
Dan Hennessy – Vice President, Field Medical Affairs
As Chief Executive Officer of Within3, Lance Hill brings his own brand of energy, leadership and vision to the company.
With the belief that deeper engagement among healthcare professionals results in improved healthcare and better patient outcomes, Lance strategizes with global healthcare decision makers on how to integrate digital collaboration solutions into their businesses as an effective new channel of communication.
Prior to joining Within3, Lance served as the Vice President and General Manager of the worldwide Service Oriented Architecture business unit for the webMethods Corporation, an international leader in enterprise software. With annual revenues exceeding $200 million, webMethods was acquired in 2007 by German giant, Software AG, for $546 million.
Recruited directly from the University of Toledo by tech giant IBM, Lance led the design and implementation of global telecommunication networks for Fortune 500 businesses and major healthcare organizations, as well as consulted and lectured on worldwide technology strategies. He also developed training, methodology and best practices for Global Services consultants. Lance subsequently joined a top 10 U.S. financial services firm where he served as the Vice President of Enterprise Engineering and founded its Fusion Technology Group, dedicated to accelerating corporate adoption of new technologies and business processes.
A veteran in the technology industry, Lance dedicates himself to work he strongly believes in — improving healthcare by providing an easy-to-use, always accessible, digital collaboration solution for healthcare professionals and industry leaders to connect, communicate and collaborate.
Assistant General Counsel, Commercial Brands
David Jacobs – Assistant General Counsel, Commercial Brands
David M. Jacobs has over ten years of experience in the biopharmaceutical industry. He presently serves as Assistant General Counsel, Commercial Brands, at Daiichi Sankyo, Inc. where he supports Global and U.S. clients on a broad array of issues related to the Federal Food, Drug and Cosmetic Act, Foreign Corrupt Practices Act, AntiKickback Act, False Claims Act, HIPAA, advertising and promotion, product labeling, Compliance, State Law and regulatory policy. David also supports the company’s functions responsible for managed markets and key account management, including government price reporting, payer marketing, market access, and the account management relationships with managed care organizations, pharmacy benefit managers, group purchasing organizations and integrated delivery networks. Prior to joining Daiichi Sankyo, David worked for Bristol-Myers Squibb providing general legal and promotion compliance support to the U.S. Sales, Marketing and Medical organizations, as well as the Middle East and Africa. David received his J.D. from Brooklyn Law School and a Masters in Biotechnology from Columbia University.
E. Kaye, M.D.
Chief Medical Officer
Randall Kaye – Chief Medical Officer
Medical Science Liaison
Bill Maltas – Medical Science Liaison
L. Marantz, M.D., Ph.D.
Senior Vice President, Head of Medical Affairs
Jing Marantz – Senior Vice President, Head of Medical Affairs
Director, Key Accounts
Pamela Morris – Director, Key Accounts
Executive Director, Medical Affairs
Poushali Mukherjea – Executive Director, Medical Affairs
Dr. Poushali Mukherjea has over 18 years of pharmaceutical industry experience in Medical Affairs with core responsibilities in leading global teams in both pre-launch and marketed products in multiple disease areas including CV, diabetes, and chronic kidney disease. She has hands-on experience in developing and implementing a pre-launch medical strategy and plan for a first class product in a competitive disease area. Poushali has led global teams in medical affairs building long-term product strategy, thought leader plans, Lifecycle management/Phase 4 activities, payer and access strategy support, medical communications, publication plans, and advisory board. She has extensive experience in working in complex matrix organizations with co-development and commercialization partners.
Immunotherapy Sales Specialist
Marty Perz – Immunotherapy Sales Specialist
Principal Medical Science Liaison
Sandra Petralia – Principal Medical Science Liaison
L. Phillips, M.D.
Vice President and Head of Global Medical Affairs
Terri Phillips – Vice President and Head of Global Medical Affairs
W. Ravotti, DHSc, PA-C
Senior Associate Director CDMA, Field-Based Medicine Respiratory MSLs
Michael Ravotti – Senior Associate Director CDMA, Field-Based Medicine Respiratory MSLs
Vice President, Medical Affairs
Howard Rutman – Vice President, Medical Affairs
Senior Director and Head, Field Medical Affairs
Sagar Shah – Senior Director and Head, Field Medical Affairs
Vice President, Medical Affairs
Archie Stone, Ph.D. – Vice President, Medical Affairs
Vice President, Head, Medical Affairs
Beate Stych – Vice President, Head, Medical Affairs
Arora Sukhatme, Pharm.D.
Head of U.S. Medical Affairs
Monica Sukhatme – Head of U.S. Medical Affairs
J. White, M.D.
Head, U.S. Medical Affairs
Davida White – Head, U.S. Medical Affairs
Medical Director Gastroenterology, U.S. Medical Affairs
Javier Zambrano – Medical Director Gastroenterology, U.S. Medical Affairs
Senior Associate General Counsel
Dan Zavodnick currently serves as Regulatory Counsel at Actavis, Inc.. Dan provides proactive legal support to senior management, product brand teams and client groups across the organization, advising and educating on regulations pertaining to branded pharmaceutical products. He serves on multiple brand advertising and promotional review committees, reviewing and analyzing risk-benefit profiles of commercial and medical communications, activities and initiatives. Previously, Dan served as Corporate Counsel at Bayer HealthCare; Head of the U.S. Legal Department of LEO Pharma, Inc.; Regulatory Attorney at Astellas Pharma US, Inc.; Associate Senior Counsel at Eisai Inc.; and Corporate Associate at Cole, Schotz, Meisel, Forman & Leonard, P.A. He is admitted to both the New Jersey and New York bars. Dan received his J.D. from Fordham University School of Law, where he was a Staff Member of the Fordham Journal of Corporate and Financial Law and the Writing and Research Editor of the Fordham Sports Law Forum, and received his B.A. from the University of Pennsylvania.